Advancing biopharmaceutical manufacturing with a new CHO cell isolation platform

The University of Manchester's Centre of Excellence in Biopharmaceuticals (COEBP) has developed a biopharmaceutical manufacturing platform that allows rapid isolation of high-producing CHO cell populations.

The researchers needed to evaluate the antibody titer in hundreds of study samples. Due to the substantial manual processing necessary for ELISA, cell cultures were frozen to regulate throughput. Data was obtained retrospectively, delaying decisions and resulting in lengthy, unproductive periods.

The lab introduced antibody titer measurement using the Amperia™ system, streamlining measurement from crude samples and enabling same-day results.

Freezing and thawing cell cultures can delay reintroduction into productive workflows. Reducing the need for sample freezing helped limit extended periods of unproductive time.

Key takeaways

Amperia™ reduces the need to batch and store samples prior to analysis, helping avoid delays of up to three weeks.

About Abselion

Abselion started in 2018, at that time under the name HexagonFab, in a small corner of a laboratory at the University of Cambridge.

We set out with the humble goal to make protein research simpler. Scientists should be able to pursue their passion for discovery and innovation, rather than spend their valuable time with tedious, manual tasks. With RED we had access to the ideal technology to create this product. A product that is so compact that it could fit on every bench, and so affordable that it is accessible to everyone. Over the years we have designed, built and tested our first product Amperia and we’re proud to introduce it to the world.​


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Dec 12, 2025 at 10:47 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Abselion. (2025, December 12). Advancing biopharmaceutical manufacturing with a new CHO cell isolation platform. News-Medical. Retrieved on December 12, 2025 from https://www.news-medical.net/whitepaper/20251212/Advancing-biopharmaceutical-manufacturing-with-a-new-CHO-cell-isolation-platform.aspx.

  • MLA

    Abselion. "Advancing biopharmaceutical manufacturing with a new CHO cell isolation platform". News-Medical. 12 December 2025. <https://www.news-medical.net/whitepaper/20251212/Advancing-biopharmaceutical-manufacturing-with-a-new-CHO-cell-isolation-platform.aspx>.

  • Chicago

    Abselion. "Advancing biopharmaceutical manufacturing with a new CHO cell isolation platform". News-Medical. https://www.news-medical.net/whitepaper/20251212/Advancing-biopharmaceutical-manufacturing-with-a-new-CHO-cell-isolation-platform.aspx. (accessed December 12, 2025).

  • Harvard

    Abselion. 2025. Advancing biopharmaceutical manufacturing with a new CHO cell isolation platform. News-Medical, viewed 12 December 2025, https://www.news-medical.net/whitepaper/20251212/Advancing-biopharmaceutical-manufacturing-with-a-new-CHO-cell-isolation-platform.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.